193 related articles for article (PubMed ID: 21257763)
21. Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies.
Yuki N
Methods Mol Biol; 2010; 600():51-65. PubMed ID: 19882120
[TBL] [Abstract][Full Text] [Related]
22. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
[TBL] [Abstract][Full Text] [Related]
23. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.
Guerry P; Szymanski CM; Prendergast MM; Hickey TE; Ewing CP; Pattarini DL; Moran AP
Infect Immun; 2002 Feb; 70(2):787-93. PubMed ID: 11796612
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of the Core Oligosaccharides of Lipooligosaccharides from Campylobacter jejuni: A Putative Cause of Guillain-Barré Syndrome.
Yoshida F; Yoshinaka H; Tanaka H; Hanashima S; Yamaguchi Y; Ishihara M; Saburomaru M; Kato Y; Saito R; Ando H; Kiso M; Imamura A; Ishida H
Chemistry; 2019 Jan; 25(3):796-805. PubMed ID: 30351481
[TBL] [Abstract][Full Text] [Related]
25. Chemoenzymatic Synthesis of
Li T; Wolfert MA; Wei N; Huizinga R; Jacobs BC; Boons GJ
J Am Chem Soc; 2020 Nov; 142(46):19611-19621. PubMed ID: 33164488
[TBL] [Abstract][Full Text] [Related]
26. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
27. Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures.
Louwen R; Nieuwenhuis EE; van Marrewijk L; Horst-Kreft D; de Ruiter L; Heikema AP; van Wamel WJ; Wagenaar JA; Endtz HP; Samsom J; van Baarlen P; Akhmanova A; van Belkum A
Infect Immun; 2012 Sep; 80(9):3307-18. PubMed ID: 22778098
[TBL] [Abstract][Full Text] [Related]
28. Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.
Ang CW; Dijkstra JR; de Klerk MA; Endtz HP; van Doorn PA; Jacobs BC; Jeurissen SH; Wagenaar JA
PLoS One; 2010 Mar; 5(3):e9820. PubMed ID: 20339556
[TBL] [Abstract][Full Text] [Related]
29. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
Godschalk PC; van Belkum A; van den Braak N; van Netten D; Ang CW; Jacobs BC; Gilbert M; Endtz HP
J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514
[TBL] [Abstract][Full Text] [Related]
30. Distribution of genes related to Type 6 secretion system and lipooligosaccharide that induced ganglioside mimicry among
Serichantalergs O; Wassanarungroj P; Khemnu N; Poly F; Guerry P; Bodhidatta L; Crawford J; Swierczewski B
Gut Pathog; 2020; 12():18. PubMed ID: 32308743
[TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
Prendergast MM; Lastovica AJ; Moran AP
Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
33. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection.
Prendergast MM; Tribble DR; Baqar S; Scott DA; Ferris JA; Walker RI; Moran AP
Infect Immun; 2004 Feb; 72(2):916-22. PubMed ID: 14742536
[TBL] [Abstract][Full Text] [Related]
34. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.
Huizinga R; Easton AS; Donachie AM; Guthrie J; van Rijs W; Heikema A; Boon L; Samsom JN; Jacobs BC; Willison HJ; Goodyear CS
PLoS One; 2012; 7(3):e34416. PubMed ID: 22470569
[TBL] [Abstract][Full Text] [Related]
35. Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate.
Kanipes MI; Papp-Szabo E; Guerry P; Monteiro MA
J Bacteriol; 2006 May; 188(9):3273-9. PubMed ID: 16621820
[TBL] [Abstract][Full Text] [Related]
36. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
37. Structural heterogeneity of terminal glycans in Campylobacter jejuni lipooligosaccharides.
Semchenko EA; Day CJ; Moutin M; Wilson JC; Tiralongo J; Korolik V
PLoS One; 2012; 7(7):e40920. PubMed ID: 22815868
[TBL] [Abstract][Full Text] [Related]
38. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
[TBL] [Abstract][Full Text] [Related]
39. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion.
Louwen R; Heikema A; van Belkum A; Ott A; Gilbert M; Ang W; Endtz HP; Bergman MP; Nieuwenhuis EE
Infect Immun; 2008 Oct; 76(10):4431-8. PubMed ID: 18644887
[TBL] [Abstract][Full Text] [Related]
40. Comparison of lipooligosaccharide biosynthesis genes of Campylobacter jejuni strains with varying abilities to colonize the chicken gut and to invade Caco-2 cells.
Müller J; Meyer B; Hänel I; Hotzel H
J Med Microbiol; 2007 Dec; 56(Pt 12):1589-1594. PubMed ID: 18033824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
